Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis

Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis

ABSTRACT Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability. Anaemia is a frequent extra-articular manifestation in rheumatoid arthritis, affecting 30-70% of the patients; presenting a negative impact on patient´s quality of life. Some of the drugs used i...

Full description

Bibliographic Details
Main Authors: Ione C.P. Pereira, Nágila C.F. Sousa, Domingos M.S. Pereira, Saulo J.F. Mendes, Thayanne F. Muniz, Valderlane L.P. Colares, Bruna L.R. Silva, Cinara R.A.V. Monteiro, Mahiba M.R.S. Martins, Anita M.R. Fernandes, Elizabeth S. Fernandes
Format: Article
Language:English
Published: Academia Brasileira de Ciências 2018-06-01
Series:Anais da Academia Brasileira de Ciências
Subjects:
anaemia
rheumatoid arthritis
leflunomide
adalimumab
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502161&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502161&lng=en&tlng=en

Similar Items